Government- and industry-funded campaigns for medication disposal do work, but responsibility often falls on local health care organizations to provide education and services.
AMA J Ethics. 2022;24(10):E971-979. doi:
10.1001/amajethics.2022.971.
Lisa Patel, MD, MESc and Katie E. Lichter, MD, MPH
Health care generates a lot of waste that enters landfills, oceans, and incinerators and adversely affects communities close to waste processing and disposal areas.
AMA J Ethics. 2022;24(10):E980-985. doi:
10.1001/amajethics.2022.980.
Mismanagement of hospital waste can release harmful, deleterious contaminants into soil, water, and air and can have far-reaching environmental and public relations consequences.
AMA J Ethics. 2022;24(10):E1013-1021. doi:
10.1001/amajethics.2022.1013.
Rebekah Davis Reed, PhD, JD and Erik L. Antonsen, PhD, MD
Though the National Aeronautics and Space Administration’s collection of disaggregated genetic data for occupational surveillance and research raises numerous privacy concerns, the Genetic Information Nondiscrimination Act of 2008 allows genetic information to be used to develop personal pharmaceuticals.
AMA J Ethics. 2018;20(9):E849-856. doi:
10.1001/amajethics.2018.849.
Charles E. Binkley, MD, Michael S. Politz, MA, and Brian P. Green, PhD
If the safe-and-effective standard for judging devices’ potential as therapy or enhancement is inadequate, one might wonder whether BCI regulation should be overseen by the FDA.
AMA J Ethics. 2021;23(9):E745-749. doi:
10.1001/amajethics.2021.745.
COVID-19 underscores historical precedent for fear-driven responses that disregard autonomy among persons with low income who are also persons of color.
AMA J Ethics. 2021;23(11):E840-846. doi:
10.1001/amajethics.2021.840.